ArticleCancers2022

Consensus Molecular Subtypes Efficiently Classify Gastric Adenocarcinomas and Predict the Response to Anti-PD-1 Immunotherapy.

Xiangyan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.